Clinical features, etiology and survival in patients with restrictive cardiomyopathy: A single center experience

CONCLUSIONS: Genetic testing should be considered in every patient with RCM where light-chain amyloidosis has been excluded. Survival remains poor regardless of etiology. Increased concentrations of GDF15, hs-TNT, NT-proBNP and pericardial effusion are associated with worse prognosis. Further studies are warranted.PMID:37937352 | DOI:10.33963/v.kp.97879

Source: Kardiologia Polska - November 8, 2023 Category: Cardiology Authors: Justyna A Szczygie ł Piotr Micha łek Gra żyna Truszkowska Joann Drozd-Soko łowska Aleksandra Wr óbel Maria Franaszczyk Monika Gawor-Prokopczyk Łukasz Mazurkiewicz Mateusz Ziarkiewicz Anna Waszczuk-Gajda Marta Legatowicz-Koprowska Ewa Walczak Piotr S Source Type: research